Ati cautat: OMS
Protocol terapeutic: N030C – DUREREA CRONICĂ DIN CANCER (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: M003M – OSTEOPOROZA – ACIDUM ALENDRONICUM**; ACIDUM RISEDRONICUM**; ACIDUM ZOLENDRONICUM**; COMBINAŢII (ACIDUM ALENDRONICUM + COLECALCIFEROLUM)**; DENOSUMABUM(Prolia)**; TERIPARATIDUM**(original si biosimilar) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L050C – DCI INTERFERONUM ALFA 2A (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L016C – : DCI INTERFERON ALFA 2B (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: H006C – TUMORILE NEUROENDOCRINE – TRATAMENT CU ANALOGI DE SOMATOSTATINĂ (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: H005E – ACROMEGALIE ŞI GIGANTISM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: H004E – DCI CETRORELIXUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: G009N – DCI SOLIFENACINUM SUCCINAT (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: G008N – DCI FOLLITROPINUM BETA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: G006N – DCI LUTROPINA ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
